Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
Year: 2008
Type: article
Abstract: Aspergillus species have emerged as an important cause of life-threatening infections in immunocompromised patients.This expanding population is composed of patients with prolonged neutropenia, advanced HIV infection, and inherited immunodeficiency and patients who have undergone allogeneic hematopoietic stem cell transplantation (HSCT) and/or lung transplantation.This document constitutes the guidelines of the Infectious Diseases Society of America for treatment of aspergillosis and replaces the practice guidelines for Aspergillus published in 2000 [1].The objective of these
Source: Clinical Infectious Diseases
DOI: 10.1086/525258
Institutions: National Institutes of Health, National Cancer Institute, University of Arkansas for Medical Sciences, University of Manchester, Hôpitaux Universitaires de Strasbourg, The University of Texas MD Anderson Cancer Center, Oregon Health & Science University, University of Minnesota, Minneapolis VA Medical Center, Roswell Park Comprehensive Cancer Center, Duke Medical Center, Santa Clara Valley Medical Center, Stanford University, University of Florida, The University of Texas at San Antonio Health Science Center
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2123134253